Price target
Based on analysts projections #KNTE is expected to experience a positive growth trajectory over the next year.
The current average KNTE price target, as estimated by these analysts, is $30.00.
The predictions for the future KNTE stock price range from a low of $30.00 to a high of $30.00, highlighting the variability of market expectations for KNTE.
It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.
KNTE stock forecasts by analyst
Analyst / firm | Date | Rating | Price target | Price when posted |
---|---|---|---|---|
Christopher Raymond Piper Sandler |
May 18, 2022 | Buy | 30.00 | 9.96 |
Kinnate Biopharma (KNTE) Fundamentals Checker
Financial metrics are used to evaluate financial stability which helps analysts determine if Kinnate Biopharma is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.
Neutral

Financial Scores
Updated on: 06/12/2023
Altman Z-Score: -0.4
Piotroski Score: 2.0
ESG Score
Updated on: 06/12/2023
Environmental: 59.9
Social: 58.8
Governance: 60.2
Financial Health
Updated on: 06/12/2023
DCF: Strong Buy
ROE: Strong Sell
ROA: Strong Sell
Debt to equity ratio: Neutral
Price to earnings ratio: Sell
Price to book ratio: Strong Buy
KNTE Discounted Cash Flow
Updated on: 06/12/2023
$0.000
Discounted Cash Flow Value
$0.000
Current Price
KNTE Revenues by Segment
Updated on: 06/12/2023
No available data
Revenue from Contract with Customer, Excluding Assessed Tax
KNTE Revenues by Region
Updated on: 06/12/2023
No available data
KNTE Notes Due
Updated on: 06/12/2023
CIK | Exchange | Title |
---|
There are no data to display
Kinnate Biopharma (KNTE) Social Sentiments
Monitoring bullish and bearish sentiments towards Kinnate Biopharma on Twitter and Stocktwits could help to forecast an upward or downward trend in Kinnate Biopharma stock price.